PDB Short entry for 4QMS HEADER TRANSFERASE/TRANSFERASE INHIBITOR 16-JUN-14 4QMS TITLE MST3 IN COMPLEX WITH DASATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 24; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1-303; COMPND 5 SYNONYM: MAMMALIAN STE20-LIKE PROTEIN KINASE 3, MST-3, STE20-LIKE COMPND 6 KINASE MST3, SERINE/THREONINE-PROTEIN KINASE 24 36 KDA SUBUNIT, COMPND 7 MAMMALIAN STE20-LIKE PROTEIN KINASE 3 N-TERMINAL, MST3/N, COMPND 8 SERINE/THREONINE-PROTEIN KINASE 24 12 KDA SUBUNIT, MAMMALIAN STE20- COMPND 9 LIKE PROTEIN KINASE 3 C-TERMINAL, MST3/C; COMPND 10 EC: 2.7.11.1; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MST3, STK24, STK3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS PROTEIN KINASE, MST3, STK24, STERILE 20-LIKE KINASE, ATP-BINDING, KEYWDS 2 NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, SERINE/THREONINE-TRANSFERASE, KEYWDS 3 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.H.OLESEN,C.WATTS,J.-Y.ZHU,E.SCHONBRUNN REVDAT 3 11-APR-18 4QMS 1 COMPND REMARK HETNAM REVDAT 2 13-JUL-16 4QMS 1 JRNL REVDAT 1 01-JUL-15 4QMS 0 JRNL AUTH S.H.OLESEN,J.Y.ZHU,M.P.MARTIN,E.SCHONBRUNN JRNL TITL DISCOVERY OF DIVERSE SMALL-MOLECULE INHIBITORS OF MAMMALIAN JRNL TITL 2 STERILE20-LIKE KINASE 3 (MST3). JRNL REF CHEMMEDCHEM V. 11 1137 2016 JRNL REFN ISSN 1860-7179 JRNL PMID 27135311 JRNL DOI 10.1002/CMDC.201600115 REMARK 2 REMARK 2 RESOLUTION. 1.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.50 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 23527 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 1166 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.5047 - 3.7637 0.99 2879 151 0.1535 0.1933 REMARK 3 2 3.7637 - 2.9879 0.99 2819 145 0.1739 0.2167 REMARK 3 3 2.9879 - 2.6104 0.99 2793 141 0.1898 0.2802 REMARK 3 4 2.6104 - 2.3718 1.00 2809 151 0.1880 0.2217 REMARK 3 5 2.3718 - 2.2018 0.99 2788 140 0.1647 0.2006 REMARK 3 6 2.2018 - 2.0720 1.00 2785 148 0.1526 0.1743 REMARK 3 7 2.0720 - 1.9682 0.99 2782 150 0.1581 0.2048 REMARK 3 8 1.9682 - 1.8826 0.96 2706 140 0.1832 0.2309 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.170 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.550 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2374 REMARK 3 ANGLE : 1.151 3211 REMARK 3 CHIRALITY : 0.046 353 REMARK 3 PLANARITY : 0.005 405 REMARK 3 DIHEDRAL : 14.261 916 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QMS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000086251. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23554 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.880 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07800 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 47.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.88 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 85.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.14300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 14.10 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 3CKW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12.5 MG/ML MST3, 1 MM DASATINIB, 25 MM REMARK 280 TRIS, PH 8.0, 50 MM HEPES PH 7.5, 125 MM SODIUM CHLORIDE, 100 MM REMARK 280 MAGNESIUM CHLORIDE, 15% PEG 400, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.56650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -6 REMARK 465 PRO A -5 REMARK 465 LEU A -4 REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 GLU A -1 REMARK 465 PHE A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 SER A 4 REMARK 465 PRO A 5 REMARK 465 VAL A 6 REMARK 465 GLN A 7 REMARK 465 SER A 8 REMARK 465 GLY A 9 REMARK 465 LEU A 10 REMARK 465 PRO A 11 REMARK 465 GLY A 12 REMARK 465 MET A 13 REMARK 465 GLN A 14 REMARK 465 SER A 299 REMARK 465 HIS A 300 REMARK 465 ASP A 301 REMARK 465 ASP A 302 REMARK 465 SER A 303 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 81 O HOH A 639 2.13 REMARK 500 O PHE A 229 O HOH A 662 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 27 -145.53 -109.20 REMARK 500 LYS A 32 146.47 61.29 REMARK 500 ALA A 60 -72.53 -71.58 REMARK 500 ASP A 92 -115.44 54.33 REMARK 500 ASP A 144 46.75 -142.09 REMARK 500 ASP A 162 88.65 59.12 REMARK 500 ASP A 197 -149.40 -141.67 REMARK 500 LYS A 279 -169.73 -129.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1N1 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4QML RELATED DB: PDB REMARK 900 RELATED ID: 4QMM RELATED DB: PDB REMARK 900 RELATED ID: 4QMN RELATED DB: PDB REMARK 900 RELATED ID: 4QMO RELATED DB: PDB REMARK 900 RELATED ID: 4QMP RELATED DB: PDB REMARK 900 RELATED ID: 4QMQ RELATED DB: PDB REMARK 900 RELATED ID: 4QMR RELATED DB: PDB REMARK 900 RELATED ID: 4QMS RELATED DB: PDB REMARK 900 RELATED ID: 4QMU RELATED DB: PDB REMARK 900 RELATED ID: 4QMV RELATED DB: PDB REMARK 900 RELATED ID: 4QMW RELATED DB: PDB REMARK 900 RELATED ID: 4QMX RELATED DB: PDB REMARK 900 RELATED ID: 4QMY RELATED DB: PDB REMARK 900 RELATED ID: 4QMZ RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CRYSTALLIZED SEQUENCE REFERS TO THE ISOFORM A DBREF 4QMS A 1 303 UNP Q9Y6E0 STK24_HUMAN 1 303 SEQADV 4QMS GLY A -6 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMS PRO A -5 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMS LEU A -4 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMS GLY A -3 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMS SER A -2 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMS GLU A -1 UNP Q9Y6E0 EXPRESSION TAG SEQADV 4QMS PHE A 0 UNP Q9Y6E0 EXPRESSION TAG SEQRES 1 A 310 GLY PRO LEU GLY SER GLU PHE MET ALA HIS SER PRO VAL SEQRES 2 A 310 GLN SER GLY LEU PRO GLY MET GLN ASN LEU LYS ALA ASP SEQRES 3 A 310 PRO GLU GLU LEU PHE THR LYS LEU GLU LYS ILE GLY LYS SEQRES 4 A 310 GLY SER PHE GLY GLU VAL PHE LYS GLY ILE ASP ASN ARG SEQRES 5 A 310 THR GLN LYS VAL VAL ALA ILE LYS ILE ILE ASP LEU GLU SEQRES 6 A 310 GLU ALA GLU ASP GLU ILE GLU ASP ILE GLN GLN GLU ILE SEQRES 7 A 310 THR VAL LEU SER GLN CYS ASP SER PRO TYR VAL THR LYS SEQRES 8 A 310 TYR TYR GLY SER TYR LEU LYS ASP THR LYS LEU TRP ILE SEQRES 9 A 310 ILE MET GLU TYR LEU GLY GLY GLY SER ALA LEU ASP LEU SEQRES 10 A 310 LEU GLU PRO GLY PRO LEU ASP GLU THR GLN ILE ALA THR SEQRES 11 A 310 ILE LEU ARG GLU ILE LEU LYS GLY LEU ASP TYR LEU HIS SEQRES 12 A 310 SER GLU LYS LYS ILE HIS ARG ASP ILE LYS ALA ALA ASN SEQRES 13 A 310 VAL LEU LEU SER GLU HIS GLY GLU VAL LYS LEU ALA ASP SEQRES 14 A 310 PHE GLY VAL ALA GLY GLN LEU THR ASP THR GLN ILE LYS SEQRES 15 A 310 ARG ASN TPO PHE VAL GLY THR PRO PHE TRP MET ALA PRO SEQRES 16 A 310 GLU VAL ILE LYS GLN SER ALA TYR ASP SER LYS ALA ASP SEQRES 17 A 310 ILE TRP SER LEU GLY ILE THR ALA ILE GLU LEU ALA ARG SEQRES 18 A 310 GLY GLU PRO PRO HIS SER GLU LEU HIS PRO MET LYS VAL SEQRES 19 A 310 LEU PHE LEU ILE PRO LYS ASN ASN PRO PRO THR LEU GLU SEQRES 20 A 310 GLY ASN TYR SER LYS PRO LEU LYS GLU PHE VAL GLU ALA SEQRES 21 A 310 CYS LEU ASN LYS GLU PRO SER PHE ARG PRO THR ALA LYS SEQRES 22 A 310 GLU LEU LEU LYS HIS LYS PHE ILE LEU ARG ASN ALA LYS SEQRES 23 A 310 LYS THR SER TYR LEU THR GLU LEU ILE ASP ARG TYR LYS SEQRES 24 A 310 ARG TRP LYS ALA GLU GLN SER HIS ASP ASP SER MODRES 4QMS TPO A 178 THR PHOSPHOTHREONINE HET TPO A 178 11 HET 1N1 A 401 33 HET EDO A 402 4 HET CL A 403 1 HETNAM TPO PHOSPHOTHREONINE HETNAM 1N1 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL) HETNAM 2 1N1 PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3- HETNAM 3 1N1 THIAZOLE-5-CARBOXAMIDE HETNAM EDO ETHANE-1,2-DIOL HETNAM CL CHLORIDE ION HETSYN TPO PHOSPHONOTHREONINE HETSYN 1N1 DASATINIB HETSYN EDO ETHYLENE GLYCOL FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 1N1 C22 H26 CL N7 O2 S FORMUL 3 EDO C2 H6 O2 FORMUL 4 CL CL 1- FORMUL 5 HOH *170(H2 O) HELIX 1 1 PRO A 20 GLU A 22 5 3 HELIX 2 2 GLU A 58 ALA A 60 5 3 HELIX 3 3 GLU A 63 CYS A 77 1 15 HELIX 4 4 ALA A 107 GLU A 112 1 6 HELIX 5 5 ASP A 117 GLU A 138 1 22 HELIX 6 6 LYS A 146 ALA A 148 5 3 HELIX 7 7 THR A 182 MET A 186 5 5 HELIX 8 8 ALA A 187 LYS A 192 1 6 HELIX 9 9 SER A 198 GLY A 215 1 18 HELIX 10 10 HIS A 223 ASN A 234 1 12 HELIX 11 11 SER A 244 LEU A 255 1 12 HELIX 12 12 GLU A 258 ARG A 262 5 5 HELIX 13 13 THR A 264 LEU A 269 1 6 HELIX 14 14 HIS A 271 ALA A 278 1 8 HELIX 15 15 LYS A 280 TYR A 283 5 4 HELIX 16 16 LEU A 284 GLN A 298 1 15 SHEET 1 A 6 LYS A 17 ALA A 18 0 SHEET 2 A 6 TYR A 85 LYS A 91 1 O LEU A 90 N LYS A 17 SHEET 3 A 6 LYS A 94 GLU A 100 -1 O ILE A 98 N TYR A 86 SHEET 4 A 6 VAL A 49 ASP A 56 -1 N LYS A 53 O ILE A 97 SHEET 5 A 6 GLU A 37 ASP A 43 -1 N PHE A 39 O ILE A 52 SHEET 6 A 6 PHE A 24 GLY A 31 -1 N ILE A 30 O VAL A 38 SHEET 1 B 3 GLY A 105 SER A 106 0 SHEET 2 B 3 VAL A 150 LEU A 152 -1 O LEU A 152 N GLY A 105 SHEET 3 B 3 VAL A 158 LEU A 160 -1 O LYS A 159 N LEU A 151 SHEET 1 C 2 LYS A 140 ILE A 141 0 SHEET 2 C 2 GLY A 167 GLN A 168 -1 O GLY A 167 N ILE A 141 LINK C ASN A 177 N TPO A 178 1555 1555 1.33 LINK C TPO A 178 N PHE A 179 1555 1555 1.33 CISPEP 1 LYS A 32 GLY A 33 0 -0.06 CISPEP 2 ALA A 60 GLU A 61 0 -26.34 SITE 1 AC1 11 ILE A 30 ALA A 51 LYS A 53 GLU A 70 SITE 2 AC1 11 MET A 99 GLU A 100 TYR A 101 LEU A 102 SITE 3 AC1 11 GLY A 103 HOH A 568 HOH A 647 SITE 1 AC2 6 THR A 238 LYS A 248 GLU A 249 GLU A 252 SITE 2 AC2 6 HOH A 509 HOH A 601 SITE 1 AC3 3 GLY A 103 SER A 153 GLU A 154 CRYST1 47.486 55.133 60.236 90.00 111.35 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021059 0.000000 0.008231 0.00000 SCALE2 0.000000 0.018138 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017824 0.00000